Tolerization Reduces Intolerance to Pegloticase and Prolongs the Urate Lowering Effect
Clinical trial NCT02598596 · COMPLETED
Trial details
- NCT number
- NCT02598596
- Sponsor
- Ampel BioSolutions, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2020-04-13
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.